Supporting the Entire Patient Network

Patient-Focused,
Ergo, Better Trials

Therapeutic Expertise, Ergo, Informed Trial Strategies

U.S. Presence, Ergo, Convenient to Biotechs

Your Dedicated Oncology, Rare Disease & Complex Trials CRO in the U.S. and Globally

Ergomed Clinical Research is the trusted CRO of choice for oncology, rare disease, and complex clinical trials in the U.S. and worldwide. With over 25 years of experience and a deep bench of more than 100 MDs and PhDs, our scientific and medical expertise empowers sponsors to overcome complexity with confidence. From early-phase planning to global trial execution, we deliver tailored, high-quality clinical research solutions that improve outcomes and accelerate development timelines.
About Ergomed
Ergomed Consulting
Strategic Regulatory and Clinical Development Expertise to Accelerate Drug Approval and Global Market Access

Drawing on decades of experience at the forefront of drug development, our team can help you navigate—and anticipate—challenges at every stage of the drug development lifecycle. Our diverse expertise, backed by insights from across Ergomed, allows us to provide unparalleled support from early planning through trial design, regulatory guidance, real world evidence generation, and post-launch insights. Count on us to help eliminate obstacles and speed your product’s global success.

Discover More

Deep Scientific Expertise

Ergomed Clinical Research is a leading Contract Research Organization (CRO) with a team of experienced scientists and industry experts who offer unparalleled knowledge and innovative approaches to clinical research. Our deep understanding of regulatory landscapes, cutting-edge technology, and data-driven methodologies allows us to deliver customized solutions that expedite the development and approval of safe and effective therapies.

Patient-Centric Clinical Trials

At Ergomed CRO, our commitment to patient-centric solutions is deeply rooted in our origins as practicing physicians. A shared mission drives our team to make a difference. We actively collaborate with advocacy groups, caregivers, and trusted physicians to understand the patient journey better. This collaborative approach enables us to expedite the delivery of life-changing medicines to more patients faster, underscoring our patient-centric focus.

Ergomed CARE™
Improved Patient Enrollment, Engagement, Retention

Ergomed CARE™ is not just another clinical trial support system. Our proprietary, innovative approach seamlessly supports patients, investigators, and clinical sites throughout the trial. This unique service, Ergomed CARE™, is a testament to our commitment to improving patient enrollment, satisfaction, and retention, setting us apart from other CROs.

Discover More

We are global oncology and orphan drug development leaders backed by 25 years of experience. We provide high-quality, innovative clinical research services and solutions tailored to the needs of even the most complex clinical trials.

Therapeutic Expertise

Complex Clinical Trials

Clinical trials are increasingly complex due to expanding regulatory requirements, especially in drug development for novel treatments such as cell and gene therapies, oncolytic viruses, biologics, and personalized medicines. Our experts excel in planning and executing complex trials involving vulnerable populations, including children and those with rare diseases.

Learn More

Therapeutic Expertise

Rare Disease

Rare disease often involves advanced therapeutic products and pediatric patients, each raising the complexity and challenges of trials. We know how to deliver trials with small populations and highly advanced therapeutics, offering hope for patients with rare diseases and their families.

Learn More

Therapeutic Expertise

Oncology Clinical Trials Solutions

We understand the nuances and complexities of oncology trials and how to ensure the setup maximizes future success. Ergomed’s complete solution for oncology trials delivers genuine expertise and robust processes to provide excellence in execution.

Learn More
Global Coverage

  • Active Studies
  • Office Location
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

offices worldwide

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
,
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
+

professionals

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
+

clinical trials managed

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
,
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
+

studies completed

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
k +

patients studies annually

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
+

countries with active trials

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
,
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
+

active sites globally

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
k +

total sites globally

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
+

oncology studies

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
+

rare disease studies

With a presence in over 100 countries, Ergomed offers true global clinical trial delivery—helping sponsors navigate regulatory complexities, diverse populations, and operational challenges across regions. Our global infrastructure and local insight enable us to manage even the most demanding trials with precision and agility. With senior leadership and operational hubs in Raleigh and Boston, Ergomed combines global scale with a strong U.S. footprint—providing responsive, regionally informed support for clinical development across North America and beyond.

Why Ergomed?

Our tailored, comprehensive, high-quality clinical research services and solutions support even the most complex clinical trials.

We Are Invested in Your Success with Customized Site Support

Patient-Focused Oncology, Rare Disease, & Complex Trials CRO

Highly Skilled Staff, Driven by Science

Strong U.S. Presence

Learn More
What Our Partners Say
Chief Executive Officer

US-based Biotechnology Company

“

We think that increases in enrollment rate in our trials in recent months are, in part, due to addition of new centers and intense site support by our clinical research company Ergomed.“

Chief Executive Officer

US-based Biotechnology Company

“

Ergomed is a trusted partner. Our past experience taught us that they are highly competent and motivated. Their enrolment was fast and the study was clean.”

Clinical Research Manager

European Pharmaceutical Company

“

Ergomed has always treated our projects with care, and the conduct of the study is unheard of in this industry. Balancing what is required and what is nice has not always been straightforward, with many parties involved. The Ergomed team has always tried to have our best interest at heart, which I appreciated.”

Senior Vice President, Head of Clinical Development

US-based Biotechnology Company

“

I appreciate everyone’s tremendous efforts. It’s so exciting to have dosed the first patient in Europe—big achievement, and the start of a strong European presence for sure!”

Associate Director, Clinical Operations

US-based Pharmaceutical Company

“

Ergomed’s study team members’ commitment and dedication have enabled the start of this phase and we greatly appreciate all your efforts.”

Vice President of Product Development

European Biotechnology Company

“

Appreciated recruitment ahead of schedule and collaborative approach across the organization – highlighting Ergomed transparency.”

Senior Clinical Trials Manager

US-based Biotechnology Company

“

Shout out to Ergomed’s Regulatory Affairs and Feasibility teams for their excellent communication and thorough, proactive support. They’ve been instrumental in driving feasibility efforts and ensuring clear, reliable regulatory guidance.”

Dedicated Partnership, Ergo, Successful Outcomes

Discover Our Latest Insights

Access Ergomed's resources for the latest in clinical trial trends and innovations.